CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.

Saved in:
Bibliographic Details
Title: CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.
Authors: Frantzi M; Mosaiques diagnostics GmbH, Hannover, Germany., Gomez Gomez E; Urology Department, Reina Sofía University Hospital, Cordoba, Spain.; Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba (UCO), Cordoba, Spain., Blanca Pedregosa A; Urology Department, Reina Sofía University Hospital, Cordoba, Spain.; Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain., Valero Rosa J; Urology Department, Reina Sofía University Hospital, Cordoba, Spain.; Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain., Latosinska A; Mosaiques diagnostics GmbH, Hannover, Germany., Culig Z; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Merseburger AS; Department of Urology, University Clinic of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany., Luque RM; Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain.; Department of Cell Biology, Physiology and Immunology, University of Cordoba (UCO), Cordoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Madrid, Spain.; Agrifood Campus of International Excellence (CeiA3), Cordoba, Spain., Requena Tapia MJ; Urology Department, Reina Sofía University Hospital, Cordoba, Spain.; Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain., Mischak H; Mosaiques diagnostics GmbH, Hannover, Germany., Carrasco Valiente J; Urology Department, Reina Sofía University Hospital, Cordoba, Spain. julia.carrasco.sspa@juntadeandalucia.es.; Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), Cordoba, Spain. julia.carrasco.sspa@juntadeandalucia.es.
Source: British journal of cancer [Br J Cancer] 2019 Jun; Vol. 120 (12), pp. 1120-1128. Date of Electronic Publication: 2019 May 16.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-019-0472-z